A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
L. Q. M. Chow, N. Blais, D. J. Jonker, S. A. Laurie, S. G. Diab, C. Canil, M. McWilliam, A. Thall, A. Ruiz-Garcia, K. Zhang, L. Tye, R. C. Chao, D. R. CamidgeVolume:
69
Language:
english
Pages:
14
DOI:
10.1007/s00280-011-1755-0
Date:
March, 2012
File:
PDF, 312 KB
english, 2012